Literature DB >> 1700833

Overlapping cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5 hemagglutinin.

C E Hioe1, N Dybdahl-Sissoko, M Philpott, V S Hinshaw.   

Abstract

To define the recognition site of cytotoxic T lymphocytes (CTLs) on influenza virus H5 hemagglutinin (HA), an H5 HA-specific CTL clone was examined for the ability to recognize monoclonal antibody-selected HA variants of influenza virus A/Turkey/Ontario/7732/66 (H5N9). On the basis of 51Cr release assays with the variants, a CTL epitope was located near residue 168 of H5 HA. To define the epitope more precisely, a series of overlapping peptides corresponding to this region was synthesized and tested for CTL recognition. The minimum peptide recognized by the CTL clone encompassed residues 158 to 169 of H5 HA. Relative to the H3 HA three-dimensional structure, this CTL epitope is located near the distal tip of the HA molecule, also known as a major B-cell epitope on H3 HA. A single mutation at residue 168 (Lys to Glu) in the H5 HA variants abolished CTL recognition; this same amino acid was shown previously to be critical for B-cell recognition (M. Philpott, C. Hioe, M. Sheerar, and V. S. Hinshaw, J. Virol. 64:2941-2947, 1990). Additionally, mutations within this region of the HA molecule were associated with attenuation of the highly virulent A/Turkey/Ontario/7732/66 (H5N9) (M. Philpott, B. C. Easterday, and V.S. Hinshaw, J. Virol. 63:3453-3458, 1989). When tested for recognition of other H5 viruses, the CTL clone recognized the HA of A/Turkey/Ireland/1378/83 (H5N8) but not that of A/Chicken/Pennsylvania/1370/83 (H5N2), even though these viruses contain identical HA amino acid 158-to-169 sequences. These results suggest that differences outside the CTL epitope affected CTL recognition of the intact HA molecule. The H5 HA site defined in these studies is, therefore, important in both CTL and B-cell recognition, as well as the pathogenesis of the virus.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700833      PMCID: PMC248799     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Distinct epitopes recognized by I-Ad-restricted T-cell clones within antigenic site E on influenza virus hemagglutinin.

Authors:  L E Brown; R A Ffrench; J M Gawler; D C Jackson; M L Dyall-Smith; E M Anders; G W Tregear; L Duncan; P A Underwood; D O White
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

2.  Complete sequence of a cDNA clone of the hemagglutinin gene of influenza A/Chicken/Scotland/59 (H5N1) virus: comparison with contemporary North American and European strains.

Authors:  B K De; G G Brownlee; A P Kendal; M W Shaw
Journal:  Nucleic Acids Res       Date:  1988-05-11       Impact factor: 16.971

3.  Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence.

Authors:  A R Townsend; J Bastin; K Gould; G G Brownlee
Journal:  Nature       Date:  1986 Dec 11-17       Impact factor: 49.962

4.  Cytotoxic T lymphocyte recognition sites on influenza virus hemagglutinin.

Authors:  J V Torres; P R Wyde; M Z Atassi
Journal:  Immunol Lett       Date:  1988-09       Impact factor: 3.685

5.  Molecular analyses of the hemagglutinin genes of H5 influenza viruses: origin of a virulent turkey strain.

Authors:  Y Kawaoka; A Nestorowicz; D J Alexander; R G Webster
Journal:  Virology       Date:  1987-05       Impact factor: 3.616

6.  Cytotoxic T lymphocytes recognize a fragment of influenza virus matrix protein in association with HLA-A2.

Authors:  F Gotch; J Rothbard; K Howland; A Townsend; A McMichael
Journal:  Nature       Date:  1987 Apr 30-May 6       Impact factor: 49.962

7.  Cytotoxic T lymphocytes recognize a cross-reactive epitope on the transmembrane region of influenza H1 and H2 hemagglutinins.

Authors:  K Kuwano; T J Braciale; F A Ennis
Journal:  Viral Immunol       Date:  1989       Impact factor: 2.257

8.  Class I major histocompatibility complex-restricted T lymphocyte recognition of the influenza hemagglutinin. Overlap between class I cytotoxic T lymphocytes and antibody sites.

Authors:  M T Sweetser; V L Braciale; T J Braciale
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

9.  Use of synthetic peptides of influenza nucleoprotein to define epitopes recognized by class I-restricted cytotoxic T lymphocytes.

Authors:  J Bastin; J Rothbard; J Davey; I Jones; A Townsend
Journal:  J Exp Med       Date:  1987-06-01       Impact factor: 14.307

10.  Mouse H-2k-restricted cytotoxic T cells recognize antigenic determinants in both the HA1 and HA2 subunits of the influenza A/PR/8/34 hemagglutinin.

Authors:  K G Gould; H Scotney; A R Townsend; J Bastin; G G Brownlee
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

View more
  5 in total

1.  Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization.

Authors:  Wentao Gao; Adam C Soloff; Xiuhua Lu; Angela Montecalvo; Doan C Nguyen; Yumi Matsuoka; Paul D Robbins; David E Swayne; Ruben O Donis; Jacqueline M Katz; Simon M Barratt-Boyes; Andrea Gambotto
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

2.  bcl-2 alters influenza virus yield, spread, and hemagglutinin glycosylation.

Authors:  C W Olsen; J C Kehren; N R Dybdahl-Sissoko; V S Hinshaw
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

3.  Human immunodeficiency virus vectors for inducible expression of foreign genes.

Authors:  G L Buchschacher; A T Panganiban
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

4.  Patterns of predicted T-cell epitopes associated with antigenic drift in influenza H3N2 hemagglutinin.

Authors:  E Jane Homan; Robert D Bremel
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

5.  Analysis of overlapping T- and B-cell antigenic sites on rubella virus E1 envelope protein. Influence of HLA-DR4 polymorphism on T-cell clonal recognition.

Authors:  D Ou; L A Mitchell; M Ho; D Dćarie; A J Tingle; G T Nepom; M Lacroix; M Zrein
Journal:  Hum Immunol       Date:  1994-03       Impact factor: 2.850

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.